Erleada 60mg 120 tabs

Erleada 60mg contains apalutamide, an androgen receptor inhibitor used to treat certain types of prostate cancer. Prostate cancer cells can depend on androgens, including testosterone, to grow and survive. Apalutamide works by blocking androgen receptors, preventing these hormones from activating signals that promote cancer cell growth.

By inhibiting androgen receptor activity, Erleada can help slow the progression of prostate cancer in eligible patients. It is prescribed for specific forms of prostate cancer, including non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer.

Erleada is an oral prescription medication that may be used alongside androgen deprivation therapy (ADT), depending on the diagnosis and treatment plan. The appropriate treatment depends on the cancer stage, previous therapies, overall health, and the oncologist’s assessment.

How Does Erleada 60mg Tablet Work?

Erleada 60mg is an oral targeted hormonal therapy containing apalutamide. It belongs to a class of medications called androgen receptor inhibitors, which are used to treat certain forms of prostate cancer.

Prostate cancer cells may use androgens, such as testosterone, to stimulate their growth and multiplication. Apalutamide binds to androgen receptors and prevents them from being activated by these hormones. This action interferes with the signals that help prostate cancer cells grow.

By blocking androgen receptor signaling, Erleada can help delay disease progression in eligible patients. It may also reduce the risk of cancer spreading or advancing, depending on the specific prostate cancer diagnosis and treatment setting.

This medication is commonly prescribed with androgen deprivation therapy when indicated. Treatment response varies among patients, and regular monitoring is necessary to evaluate its effectiveness and identify possible adverse reactions.

Dosage of Erleada 60mg Tablets :

Erleada 60mg contains apalutamide and is prescribed for eligible patients with specific types of prostate cancer. The dosage and treatment schedule must be determined by the treating oncologist.

The usual recommended adult dose is 240mg once daily, equivalent to four 60mg tablets taken together. However, the prescribed dose may be adjusted by the healthcare provider according to side effects, other medical conditions, drug interactions, and individual treatment requirements.

The tablets are taken by mouth and may be swallowed whole with water, with or without food. Follow the product instructions regarding administration. Do not change the prescribed dose or stop treatment without consulting the treating physician.

Erleada is often used alongside androgen deprivation therapy, unless the patient has undergone bilateral orchiectomy or the oncologist recommends another appropriate treatment plan. Regular follow-up appointments are important to monitor treatment response, blood pressure, adverse effects, and other relevant health parameters.

If a dose is missed, follow the medication guide and contact a healthcare professional if you are unsure how to proceed. Never take an extra dose to compensate for a missed one.

Benefits of Using Erleada 60mg Tablets :

Erleada 60mg is a prescription hormonal therapy used to manage certain types of prostate cancer. Its benefits depend on the patient’s diagnosis, cancer stage, and response to treatment.

• Blocks androgen receptor activity: Apalutamide interferes with hormonal signals that may encourage prostate cancer cells to grow and multiply.
• Helps delay disease progression: In eligible patients, Erleada can delay the progression of certain forms of prostate cancer.
• May reduce the risk of cancer spreading: For appropriate patients with non-metastatic castration-resistant prostate cancer, treatment can help delay the development of distant metastases.
• Supports treatment of metastatic disease: Erleada may be prescribed with androgen deprivation therapy for eligible patients with metastatic castration-sensitive prostate cancer.
• Provides oral administration: The tablet formulation allows patients to take their prescribed medication at home, with regular medical supervision.
• Offers a targeted hormonal approach: By acting on androgen receptors, apalutamide interferes with a pathway involved in prostate cancer growth.

Treatment outcomes vary, and Erleada is not suitable for every patient with prostate cancer. The oncologist will determine whether it is appropriate based on the patient’s medical history and current condition.

Side Effects of Erleada 60mg Tablets :

Erleada may cause side effects that range from mild to serious. Commonly reported adverse effects include:

• Fatigue and weakness
• High blood pressure
• Skin rash
• Joint pain
• Falls and fractures
• Reduced appetite
• Diarrhea
• Hot flashes
• Weight loss

Erleada may also cause hypothyroidism, and healthcare professionals may recommend thyroid function monitoring during treatment. Less commonly, serious reactions can occur, including seizures, severe skin reactions, and cardiovascular events. Serious falls or fractures may also require medical attention.

Seek immediate medical assistance for a seizure, severe allergic reaction, extensive blistering or peeling of the skin, chest pain, or symptoms of a stroke. Report persistent side effects or new symptoms to the treating oncologist.

Patients should inform their healthcare provider about all medications and supplements they take because apalutamide can interact with several other drugs. Regular monitoring and follow-up are essential to manage risks and assess treatment response.

Use Erleada only under the supervision of a qualified healthcare professional.

Conclusion :

Erleada 60mg contains apalutamide, an androgen receptor inhibitor used to treat specific types of prostate cancer. It helps block hormonal signals that support cancer growth and may delay disease progression in eligible patients. Dosage, treatment duration, and monitoring must be determined by an oncologist.

Important Medical Warning :

Use Erleada 60mg strictly as prescribed by your doctor. Follow your healthcare professional’s instructions regarding dosage, administration, and treatment duration. Do not self-medicate, change the dose, or discontinue treatment without medical advice. Inform your doctor about existing medical conditions and all other medications you take. This medication requires appropriate medical supervision and regular monitoring.